Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06446492 · ClinicalTrials.gov registry record · NA
Impact of Video-Enhanced Consent on Informed Decision-Making for Parents of Extremely Preterm Infants Eligible for the ViDES Study
A NA study of Understanding of Consent in Clinical Research and Implementation of Video-Consent in Clinical Research, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
- 1
- Study location
NCT06446492: Completed NA study of Understanding of Consent in Clinical Research and Implementation of Video-Consent in Clinical Research, sponsored by The University of Texas Health Science Center, Houston.
NCT06446492 is a NA study of Understanding of Consent in Clinical Research and Implementation of Video-Consent in Clinical Research that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 83 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06446492, a NA study of Understanding of Consent in Clinical Research and Implementation of Video-Consent in Clinical Research, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot randomized controlled trial evaluates the impact of video-enhanced consent compared to the usual approach. The investigators aim to assess if video-enhanced consent empowers decision-making and improves understanding in parents considering participation in the ViDES study, which investigates the effectiveness of Vitamin D supplementation in extremely preterm infants (the ViDES study is separately registered as NCT05459298).
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER ViDEO explaining study
Study Locations (1)
Texas
- McGovern Medical School at UTHealth Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2025-06-15 |
| Phase | NA |
What the finished NCT06446492 record still lists
NCT06446492 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Understanding of Consent in Clinical Research appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT06446492 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06446492 about?
NCT06446492 is a clinical study titled "Impact of Video-Enhanced Consent on Informed Decision-Making for Parents of Extremely Preterm Infants Eligible for the ViDES Study". This pilot randomized controlled trial evaluates the impact of video-enhanced consent compared to the usual approach. The investigators aim to assess if video-enhanced consent empowers decision-making and improves understanding in parents considering participation in the ViDES study, which investiga...
What is the current status of trial NCT06446492?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2024-07-01. Estimated completion is 2025-06-15.
What conditions does trial NCT06446492 study?
This clinical trial studies the following conditions: Understanding of Consent in Clinical Research, Implementation of Video-Consent in Clinical Research.
What interventions are being tested in trial NCT06446492?
The interventions under investigation include: Usual Care (OTHER), ViDEO explaining study (OTHER).
Who is sponsoring clinical trial NCT06446492?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06446492 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06446492's enrollment target sits among peer trials
83 990th of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI